Yutaka Negishi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yutaka Negishi has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Leo A. B. Joosten
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2 shared publications - Michiel Vermeulen
Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands
2 shared publications - Mihai Gheorghe Netea
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands
2 shared publications - Musa Mhlanga
Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Faculty of Natural Sciences, Radboud University, Nijmegen, Netherlands
2 shared publications - Abraham Jozef Petrus Teunissen
BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
1 shared publication Ary Serpa Neto
Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 13 August 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (11) , 2022-2033
Trained immunity suppression determines kidney allograft survival
- 13 August 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (11) , 2022-2033
Open AccessTrained immunity suppression determines kidney allograft survival
- 13 December 2023
- Published by Springer Nature in Nature Genetics
- Vol. 56 (1) , 85-99
A chromatin-regulated biphasic circuit coordinates IL-1β-mediated inflammation
Inflammation is characterized by a biphasic cycle consisting initially of a proinflammatory phase that is subsequently resolved by anti-inflammatory processes. Interleukin-1β (IL-1β) is a master regulator of proinflammation and is encoded within the same topologically associating domain (TAD) as IL-37, which is an anti-inflammatory cytokine that opposes the function of IL-1β. Within this TAD, we identified a long noncoding RNA called AMANZI, which negatively regulates IL-1β expression and trained immunity through the induction of IL37 transcription. We found that the activation of IL37 occurs through the formation of a dynamic long-range chromatin contact that leads to the temporal delay of anti-inflammatory responses. The common variant rs16944 present in AMANZI augments this regulatory circuit, predisposing individuals to enhanced proinflammation or immunosuppression. Our work illuminates a chromatin-mediated biphasic circuit coordinating expression of IL-1β and IL-37, thereby regulating two functionally opposed states of inflammation from within a single TAD.
- 13 December 2023
- Published by Springer Nature in Nature Genetics
- Vol. 56 (1) , 85-99
A chromatin-regulated biphasic circuit coordinates IL-1β-mediated inflammation
Inflammation is characterized by a biphasic cycle consisting initially of a proinflammatory phase that is subsequently resolved by anti-inflammatory processes. Interleukin-1β (IL-1β) is a master regulator of proinflammation and is encoded within the same topologically associating domain (TAD) as IL-37, which is an anti-inflammatory cytokine that opposes the function of IL-1β. Within this TAD, we identified a long noncoding RNA called AMANZI, which negatively regulates IL-1β expression and trained immunity through the induction of IL37 transcription. We found that the activation of IL37 occurs through the formation of a dynamic long-range chromatin contact that leads to the temporal delay of anti-inflammatory responses. The common variant rs16944 present in AMANZI augments this regulatory circuit, predisposing individuals to enhanced proinflammation or immunosuppression. Our work illuminates a chromatin-mediated biphasic circuit coordinating expression of IL-1β and IL-37, thereby regulating two functionally opposed states of inflammation from within a single TAD.